A pilot study: dose adaptation of capecitabine using mobile phone toxicity monitoring — supporting patients in their homes
Crossref DOI link: https://doi.org/10.1007/s00520-014-2224-1
Published Online: 2014-04-26
Published Print: 2014-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Weaver, Andrew
Love, Sharon B.
Larsen, Mark
Shanyinde, Milensu
Waters, Rachel
Grainger, Lisa
Shearwood, Vanessa
Brooks, Claire
Gibson, Oliver
Young, Annie M.
Tarassenko, Lionel
Text and Data Mining valid from 2014-04-26